News

The most extensively studied chromatin histone protein event is that determining the pattern of histone acetylation, by the enzymes histone deacetylase ... since HDAC inhibitors increase ...
the dysregulation of these genes suggests that there should be aberrant epigenetic changes other than methylation (such as aberrant histone modification) in endometriosis.
Histone deacetylase inhibitors (HDACi) are a new class of chemotherapeutic agents that have histone and nonhistone targets and have demonstrated potent anticancer activities in preclinical in ...
Stroke remains one of the leading causes of death, disability, increased economic burden and decreased quality of life around ...
Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...
DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...
BASFY starts registration for Adapzo Active, a breakthrough fungicide tackling resistant Asian Soybean Rust strains.
Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX) ...
HDAC inhibitors are promising therapeutic agents ... traditionally referred to as histone deacetylases (HDAC) 1–11, which are further grouped into classes I, II and IV. Whereas most class ...